NLS Pharmaceutics Ltd (NLSP)

3.60 -0.03 (-0.83%) USD  |  NASDAQ  |  Nov 01, 16:00
3.60 0.00 (0.00%) After-Hours: 20:00
More

NLS Pharmaceutics Debt to Equity Ratio

Debt to Equity Ratio Chart

Historical Debt to Equity Ratio Data

View and export this data back to . Upgrade now.
Date Value

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

AC Immune SA 0.00
CRISPR Therapeutics AG --
Addex Therapeutics Ltd 0.00
Molecular Partners AG 0.00
MoonLake Immunotherapeutics --

Debt to Equity Ratio Related Metrics

Total Assets (Quarterly) 1.194M
Total Liabilities (Quarterly) 10.46M
Shareholders Equity (Quarterly) -9.268M